-
Global Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Barriers to Reimbursement: Characteristics of Unfunded Medicines in Ireland (2006-2021)
Sep 9, 2025, 16:22 PM -
Leveraging Large-Language Models for Medical Code List Creation: An Example Using the Charlson Comorbidity Index
Sep 9, 2025, 16:22 PM -
Cost of Illness Studies Published Between 2010 and 2023 in Türkiye
Sep 9, 2025, 16:22 PM -
What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?
Sep 9, 2025, 16:22 PM -
The Economic Burden of Diabetes-Related Blindness and Vision Impairment in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Economic Consequences of Disease-Related Malnutrition in Poland and the Potential Cost Savings From Nutritional Interventions: A Two-Step Modeling Study
Sep 9, 2025, 16:22 PM -
Real-World Analysis of Treatment Patterns and Disease Exacerbations Among Patients Initiating Therapy for Myasthenia Gravis
Sep 9, 2025, 16:22 PM -
Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada
Sep 9, 2025, 16:22 PM -
Patients’ Advocacy Groups in Italy: An Updated Perspective on Activities and Future Directions
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
The Longevity Conundrum: Population Aging in the UK
Sep 9, 2025, 16:22 PM -
Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review
Sep 9, 2025, 16:22 PM -
Evaluating the Effectiveness of Interventions to Reduce Gender Disparities in Healthcare: An Overview of Literature Reviews
Sep 9, 2025, 16:22 PM -
A Systematic Review of Using Social Return on Investments Within Healthcare Service Evaluations: Methodological Opportunity and Challenges
Sep 9, 2025, 16:22 PM -
The Statistical Abyss: Real-World Evidence for Health Technology Assessment
Sep 9, 2025, 16:22 PM -
Long-Term Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST): Investigating a Parametric Survival Model for Extrapolations
Sep 9, 2025, 16:22 PM -
Financing Sustainable Public Health: Design of a Herpes Zoster Prevention Bond to Fund Vaccination
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Nonsquamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
The Role of Unpaid Work in Measuring the Social Costs of Disease
Sep 9, 2025, 16:22 PM
